BX Swiss TOP 30 CHF
1.472,74
PKT
+19,72
PKT
+1,36
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 18.07.24 | Novartis Outperform | Bernstein Research | |
| 18.07.24 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Richemont Buy | Jefferies & Company Inc. | |
| 18.07.24 | Givaudan Hold | Deutsche Bank AG | |
| 18.07.24 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 18.07.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 18.07.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.07.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 17.07.24 | Roche Hold | Jefferies & Company Inc. | |
| 17.07.24 | Richemont Buy | Deutsche Bank AG | |
| 17.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.07.24 | Richemont Buy | UBS AG | |
| 17.07.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 17.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 16.07.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 16.07.24 | UBS Hold | Deutsche Bank AG | |
| 16.07.24 | Richemont Buy | UBS AG | |
| 16.07.24 | Richemont Outperform | Bernstein Research | |
| 16.07.24 | Richemont Sector Perform | RBC Capital Markets | |
| 16.07.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 15.07.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 15.07.24 | Givaudan Neutral | UBS AG | |
| 15.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 15.07.24 | Richemont Buy | UBS AG | |
| 15.07.24 | Nestlé Market-Perform | Bernstein Research | |
| 15.07.24 | Roche Hold | Deutsche Bank AG | |
| 12.07.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 11.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.07.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.07.24 | Novartis Buy | Deutsche Bank AG | |
| 10.07.24 | Roche Hold | Deutsche Bank AG | |
| 10.07.24 | Roche Neutral | UBS AG | |
| 09.07.24 | Roche Neutral | UBS AG | |
| 09.07.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 08.07.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.07.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets |
